Management of Hypersensitivity Reactions to Taxanes

被引：62
|
作者：
Picard, Matthieu [1 ]
机构：
[1] Univ Montreal, Hop Maison Neuve Rosemont, Dept Med, Div Allergy & Immunol, 5415 Blvd Assompt, Montreal, PQ H1T 2M4, Canada
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2017年 / 37卷 / 04期
关键词：
Taxane; Paclitaxel; Docetaxel; Allergy; Hypersensitivity; Skin test; Desensitization and challenge; CUTANEOUS LUPUS-ERYTHEMATOSUS; ALBUMIN-BOUND PACLITAXEL; STEVENS-JOHNSON-SYNDROME; PHASE-II TRIAL; RAPID DESENSITIZATION; NAB-PACLITAXEL; COMPLEMENT ACTIVATION; CROSS-REACTIVITY; FLUID RETENTION; CREMOPHOR-EL;
D O I：
10.1016/j.iac.2017.07.004
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Taxanes are an important class of antineoplastic agents used in the treatment of a wide variety of cancers. However, paclitaxel and docetaxel, which are the most commonly used taxanes, elicit immediate hypersensitivity reactions (HSRs) in 5% to 10% of patients. Almost all patients that experience these reactions can be safely re-exposed to taxanes either through desensitization or challenge. This article describes the clinical presentation, diagnosis, and management of HSRs to taxanes and discusses the different options for their safe readministration.
引用
收藏
页码：679 / +
页数：16
相关论文
共 50 条
  • [31] Diagnosis and management of drug hypersensitivity reactions
    Romano, Antonino
    Torres, Maria J.
    Castells, Mariana
    Sanz, Maria L.
    Blanca, Miguel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (03) : S67 - S73
  • [32] Management of cutaneous heparin hypersensitivity reactions
    Ludwig, R. J.
    Schindewolf, M.
    Utikal, J.
    Lindhoff-Last, E.
    Kaufmann, R.
    Boehncke, W. H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 101 - 101
  • [33] Acute management of hypersensitivity reactions and seizures
    Griebel, ML
    EPILEPSIA, 1998, 39 : S17 - S21
  • [34] Management and preparedness for infusion and hypersensitivity reactions
    Lenz, Heinz-Josef
    ONCOLOGIST, 2007, 12 (05): : 601 - 609
  • [35] Role of skin tests in the diagnosis of hypersensitivity reactions to Taxanes. Preliminary results of a multicenter study
    Costantino, M. T.
    Cortellini, G.
    Roncallo, C.
    Cantore, M.
    Bonadonna, P.
    Pagani, M.
    ALLERGY, 2015, 70 : 86 - 87
  • [36] SEVERE HYPERSENSITIVITY REACTIONS WITH ORIGINAL AND GENERIC TAXANES: A PROSPECTIVE STUDY AT A MEDICAL ONCOLOGY UNIT IN THAILAND
    Ratanajarusiri, T.
    Sriuranpong, V.
    Tanasanvimon, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E61 - E61
  • [37] Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactions
    Briasoulis, E
    Karavasilis, V
    Pavlidis, N
    ANNALS OF ONCOLOGY, 2000, 11 (07) : 899 - 899
  • [38] Pharmacogenomics as a Tool for Management of Drug Hypersensitivity Reactions
    Perez-Sanchez, Natalia
    Jurado-Escobar, Raquel
    Dona, Inmaculada
    Soriano-Gomis, Victor
    Moreno-Aguilar, Carmen
    Bartra, Joan
    Isidoro-Garcia, Maria
    Jose Torres, Maria
    Antonio Cornejo-Garcia, Jose
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2019, 6 (01) : 1 - 17
  • [39] Diagnosis and management of hypersensitivity reactions caused by oxaliplatin
    Herrero, T.
    Tornero, P.
    Infante, S.
    Fuentes, V.
    Sanchez, M. M.
    De Barrio, M.
    Baeza, M. L.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2006, 16 (05) : 327 - 330
  • [40] Pharmacogenomics as a Tool for Management of Drug Hypersensitivity Reactions
    Natalia Pérez-Sánchez
    Raquel Jurado-Escobar
    Inmaculada Doña
    Víctor Soriano-Gomis
    Carmen Moreno-Aguilar
    Joan Bartra
    María Isidoro-García
    María José Torres
    José Antonio Cornejo-García
    Current Treatment Options in Allergy, 2019, 6 : 1 - 17
12345